Search research articles
Contact Us
Filters
Showing results (141-150 of 174) with videos related to
Page
of 18
Sort By:
Bone Marrow Transplantation
|
February 11, 2014
Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma
I Avivi, C Canals, J-P Vernant, et al.
Leukemia
|
April 17, 2025
GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party
Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Journal of Neurochemistry
|
August 29, 2018
Manganese causes neurotoxic iron accumulation via translational repression of amyloid precursor protein and H-Ferritin
Vivek Venkataramani, Thorsten R Doeppner, Desiree Willkommen, et al.
Hemasphere
|
July 26, 2023
Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients
Hannes Treiber, Verena Nilius-Eliliwi, Nicole Seifert, et al.
Scientific Reports
|
September 8, 2023
Randomized phase-III study of low-dose cytarabine and etoposide + /- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia
R F Schlenk, D Weber, J Krzykalla, et al.
ESC Heart Failure
|
September 30, 2022
Cardiovascular and metabolic determinants of quality of life in patients with cancer
Ruben Evertz, Katharina Gödde, Christine Diehl, et al.
Bone Marrow Transplantation
|
December 20, 2024
Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party
Jesús Duque-Afonso, Jürgen Finke, Maud Ngoya, et al.
Bone Marrow Transplantation
|
June 19, 2026
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL)
Anna Ossami Saidy, Ariane Boumendil, Peter Dreger, et al.
Frontiers in Immunology
|
October 13, 2023
Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party
Olaf Penack, Christophe Peczynski, Christian Koenecke, et al.
Nature Communications
|
September 20, 2024
Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models
Václav Havel, Andrew C Kruegel, Benjamin Bechand, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 174) with videos related to
Sort By:
Page
of 18
Bone Marrow Transplantation
|
February 11, 2014
Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma
I Avivi, C Canals, J-P Vernant, et al.
Leukemia
|
April 17, 2025
GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party
Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Journal of Neurochemistry
|
August 29, 2018
Manganese causes neurotoxic iron accumulation via translational repression of amyloid precursor protein and H-Ferritin
Vivek Venkataramani, Thorsten R Doeppner, Desiree Willkommen, et al.
Hemasphere
|
July 26, 2023
Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients
Hannes Treiber, Verena Nilius-Eliliwi, Nicole Seifert, et al.
Scientific Reports
|
September 8, 2023
Randomized phase-III study of low-dose cytarabine and etoposide + /- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia
R F Schlenk, D Weber, J Krzykalla, et al.
ESC Heart Failure
|
September 30, 2022
Cardiovascular and metabolic determinants of quality of life in patients with cancer
Ruben Evertz, Katharina Gödde, Christine Diehl, et al.
Bone Marrow Transplantation
|
December 20, 2024
Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party
Jesús Duque-Afonso, Jürgen Finke, Maud Ngoya, et al.
Bone Marrow Transplantation
|
June 19, 2026
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL)
Anna Ossami Saidy, Ariane Boumendil, Peter Dreger, et al.
Frontiers in Immunology
|
October 13, 2023
Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party
Olaf Penack, Christophe Peczynski, Christian Koenecke, et al.
Nature Communications
|
September 20, 2024
Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models
Václav Havel, Andrew C Kruegel, Benjamin Bechand, et al.
Page
of 18